Clinical Trials Browser

Phase 2 × Interventional × TNFSF10 protein, human × Clear all

NCT00508625 2016-06-14

A Study of AMG 951 [rhApo2L/TRAIL] in Subjects With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) Treated With Chemotherapy +/- Bevacizumab

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung